Research status and vaccination policy of human papillomavirus vaccine
10.19428/j.cnki.sjpm.2024.23791
- VernacularTitle:人乳头瘤病毒疫苗的研究现状及接种政策
- Author:
Guoliang TIAN
1
;
Yuxin HAO
2
;
Jiwei WANG
2
Author Information
1. School of Public Management， Fudan University， Shanghai 200433， China
2. School of Public Health， National Health Commission Key Laboratory of Health Technology Assessment， Fudan University， Shanghai 200032， China
- Publication Type:Review
- Keywords:
human papilloma virus;
cervical cancer;
vaccine;
inoculation policy
- From:
Shanghai Journal of Preventive Medicine
2024;36(3):297-302
- CountryChina
- Language:Chinese
-
Abstract:
Cervical cancer is a common gynecological malignant tumor. Vaccination with human papilloma virus （HPV） vaccine is of great significance to prevent condyloma acuminatum， HPV infection， and cervical cancer. This paper reviews the epidemic situation and risk factors of cervical cancer， the prevention strategies of cervical cancer， HPV types， HPV vaccine types and mechanisms of action， the safety and effectiveness of vaccines， men’s HPV vaccination， vaccination policies in various countries and so on， and further puts forward suggestions on HPV vaccination policies in China.
